Influence of enoximone on systemic and splanchnic oxygen utilization and endotoxin release following cardiopulmonary bypass
We investigated whether the administration of enoximone during and after cardiopulmonary bypass (CPB) improves splanchnic oxygen utilization and thereby gut mucosal integrity in humans by its vasodilating and inotropic properties. Surgical intensive care unit (ICU) in a university hospital. 21 patie...
Gespeichert in:
Veröffentlicht in: | Intensive care medicine 1997-03, Vol.23 (3), p.267-275 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 275 |
---|---|
container_issue | 3 |
container_start_page | 267 |
container_title | Intensive care medicine |
container_volume | 23 |
creator | LOICK, H. M MÖLLHOFF, T BERENDES, E HAMMEL, D VAN AKEN, H |
description | We investigated whether the administration of enoximone during and after cardiopulmonary bypass (CPB) improves splanchnic oxygen utilization and thereby gut mucosal integrity in humans by its vasodilating and inotropic properties.
Surgical intensive care unit (ICU) in a university hospital.
21 patients (ASA III classification) scheduled for elective coronary artery bypass grafting were enrolled in the study. After induction of general anesthesia, patients were randomly assigned to received a bolus of 0.2 mg/kg enoximone, followed by 5 microg/kg per min (enoximone group), or followed by an equal volume of saline (NaCl group) during and 24 h after the surgical procedure. The following parameters were evaluated at different time intervals: systemic and pulmonary hemodynamics, blood gas analysis of arterial, mixed venous, and liver venous blood, venous and liver venous lactate level, venous and liver venous endotoxin level and intramucosal partial pressure of carbon dioxide for calculation of intramucosal pH (pHi).
Enoximone raised cardiac output and oxygen delivery to higher levels than those observed in the NaCl group. In both groups, gastric pHi fell continuously during the study period. The values were significantly decreased 12 h following admission to the ICU. Endotoxin was not detectable at baseline. Both groups showed increased endotoxin levels, with the highest values during the first 6 h postoperatively. The hepatic venous endotoxin level was almost doubled in the NaCl group in comparison to the enoximone group. Endotoxin levels differed in the two groups 6 and 12 h after admission to the ICU.
Improvement of oxygen delivery by enoximone did not prevent gastric mucosal acidosis following CPB. However, since the increase in endotoxin levels in liver venous blood was diminished by using enoximone, the drug seems to have a beneficial effect on tissue damage and barrier function of the gut. |
doi_str_mv | 10.1007/s001340050327 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78908638</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78908638</sourcerecordid><originalsourceid>FETCH-LOGICAL-c310t-99b54e9513dcf6abed34f583d2fd4ac086f447fc88159f6f19e68c428c7917533</originalsourceid><addsrcrecordid>eNp90U1LHTEUBuAgit6qyy4LAUvpZmq-J7Ms0g9BcGPXQ27mxEYyyZjMUG_7583gRWgXXYVDnpxwzovQW0o-UULay0II5YIQSThrD9CGCs4ayrg-RBvCBWuEEuwEvSnlocpWSXqMjjuiOWN6g_5cRxcWiBZwchhievJjirWIuOzKDKO32MQBlymYaH_GWqan3T1EvMw--N9m9pWuAuKQ5vo84gwBTAHsUgjpl4_32Jo8-DQtofY2eYe3u8mUcoaOnAkFzvfnKfrx9cvd1ffm5vbb9dXnm8ZySuam67ZSQCcpH6xTZgsDF05qPjA3CGOJVk6I1lmtqeyccrQDpa1g2rYdbSXnp-jDS98pp8cFytyPvlgIdSJIS-lbXdehuK7w43_hulVKNBErvfiHPqQlxzpGTwlltMah15-bF2VzKiWD66fsx7qBivo1vf6v9Kp_t--6bEcYXvU-rnr_fn9vijXB5ZqJL6-MKcKlkvwZSpOizw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1012105083</pqid></control><display><type>article</type><title>Influence of enoximone on systemic and splanchnic oxygen utilization and endotoxin release following cardiopulmonary bypass</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>LOICK, H. M ; MÖLLHOFF, T ; BERENDES, E ; HAMMEL, D ; VAN AKEN, H</creator><creatorcontrib>LOICK, H. M ; MÖLLHOFF, T ; BERENDES, E ; HAMMEL, D ; VAN AKEN, H</creatorcontrib><description>We investigated whether the administration of enoximone during and after cardiopulmonary bypass (CPB) improves splanchnic oxygen utilization and thereby gut mucosal integrity in humans by its vasodilating and inotropic properties.
Surgical intensive care unit (ICU) in a university hospital.
21 patients (ASA III classification) scheduled for elective coronary artery bypass grafting were enrolled in the study. After induction of general anesthesia, patients were randomly assigned to received a bolus of 0.2 mg/kg enoximone, followed by 5 microg/kg per min (enoximone group), or followed by an equal volume of saline (NaCl group) during and 24 h after the surgical procedure. The following parameters were evaluated at different time intervals: systemic and pulmonary hemodynamics, blood gas analysis of arterial, mixed venous, and liver venous blood, venous and liver venous lactate level, venous and liver venous endotoxin level and intramucosal partial pressure of carbon dioxide for calculation of intramucosal pH (pHi).
Enoximone raised cardiac output and oxygen delivery to higher levels than those observed in the NaCl group. In both groups, gastric pHi fell continuously during the study period. The values were significantly decreased 12 h following admission to the ICU. Endotoxin was not detectable at baseline. Both groups showed increased endotoxin levels, with the highest values during the first 6 h postoperatively. The hepatic venous endotoxin level was almost doubled in the NaCl group in comparison to the enoximone group. Endotoxin levels differed in the two groups 6 and 12 h after admission to the ICU.
Improvement of oxygen delivery by enoximone did not prevent gastric mucosal acidosis following CPB. However, since the increase in endotoxin levels in liver venous blood was diminished by using enoximone, the drug seems to have a beneficial effect on tissue damage and barrier function of the gut.</description><identifier>ISSN: 0342-4642</identifier><identifier>EISSN: 1432-1238</identifier><identifier>DOI: 10.1007/s001340050327</identifier><identifier>PMID: 9083228</identifier><identifier>CODEN: ICMED9</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Aged ; Analysis of Variance ; Biological and medical sciences ; Blood Gas Analysis ; Cardiac Output - drug effects ; Cardiopulmonary Bypass ; Cardiotonic agents ; Cardiotonic Agents - administration & dosage ; Cardiotonic Agents - pharmacology ; Cardiovascular system ; Catheters ; Coronary vessels ; Endotoxins - blood ; Enoximone - administration & dosage ; Enoximone - pharmacology ; Female ; Fentanyl ; Heart surgery ; Hemodynamics - drug effects ; Humans ; Hydrogen-Ion Concentration ; Hypotheses ; Intensive care ; Lactates - blood ; Liver ; Male ; Medical sciences ; Middle Aged ; Oxygen Consumption - drug effects ; Patients ; Pharmacology. Drug treatments ; Pulmonary arteries ; Random Allocation ; Splanchnic Circulation - drug effects ; Surgical apparatus & instruments ; Veins & arteries</subject><ispartof>Intensive care medicine, 1997-03, Vol.23 (3), p.267-275</ispartof><rights>1997 INIST-CNRS</rights><rights>Springer-Verlag Berlin Heidelberg 1997</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c310t-99b54e9513dcf6abed34f583d2fd4ac086f447fc88159f6f19e68c428c7917533</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2603565$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9083228$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LOICK, H. M</creatorcontrib><creatorcontrib>MÖLLHOFF, T</creatorcontrib><creatorcontrib>BERENDES, E</creatorcontrib><creatorcontrib>HAMMEL, D</creatorcontrib><creatorcontrib>VAN AKEN, H</creatorcontrib><title>Influence of enoximone on systemic and splanchnic oxygen utilization and endotoxin release following cardiopulmonary bypass</title><title>Intensive care medicine</title><addtitle>Intensive Care Med</addtitle><description>We investigated whether the administration of enoximone during and after cardiopulmonary bypass (CPB) improves splanchnic oxygen utilization and thereby gut mucosal integrity in humans by its vasodilating and inotropic properties.
Surgical intensive care unit (ICU) in a university hospital.
21 patients (ASA III classification) scheduled for elective coronary artery bypass grafting were enrolled in the study. After induction of general anesthesia, patients were randomly assigned to received a bolus of 0.2 mg/kg enoximone, followed by 5 microg/kg per min (enoximone group), or followed by an equal volume of saline (NaCl group) during and 24 h after the surgical procedure. The following parameters were evaluated at different time intervals: systemic and pulmonary hemodynamics, blood gas analysis of arterial, mixed venous, and liver venous blood, venous and liver venous lactate level, venous and liver venous endotoxin level and intramucosal partial pressure of carbon dioxide for calculation of intramucosal pH (pHi).
Enoximone raised cardiac output and oxygen delivery to higher levels than those observed in the NaCl group. In both groups, gastric pHi fell continuously during the study period. The values were significantly decreased 12 h following admission to the ICU. Endotoxin was not detectable at baseline. Both groups showed increased endotoxin levels, with the highest values during the first 6 h postoperatively. The hepatic venous endotoxin level was almost doubled in the NaCl group in comparison to the enoximone group. Endotoxin levels differed in the two groups 6 and 12 h after admission to the ICU.
Improvement of oxygen delivery by enoximone did not prevent gastric mucosal acidosis following CPB. However, since the increase in endotoxin levels in liver venous blood was diminished by using enoximone, the drug seems to have a beneficial effect on tissue damage and barrier function of the gut.</description><subject>Aged</subject><subject>Analysis of Variance</subject><subject>Biological and medical sciences</subject><subject>Blood Gas Analysis</subject><subject>Cardiac Output - drug effects</subject><subject>Cardiopulmonary Bypass</subject><subject>Cardiotonic agents</subject><subject>Cardiotonic Agents - administration & dosage</subject><subject>Cardiotonic Agents - pharmacology</subject><subject>Cardiovascular system</subject><subject>Catheters</subject><subject>Coronary vessels</subject><subject>Endotoxins - blood</subject><subject>Enoximone - administration & dosage</subject><subject>Enoximone - pharmacology</subject><subject>Female</subject><subject>Fentanyl</subject><subject>Heart surgery</subject><subject>Hemodynamics - drug effects</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Hypotheses</subject><subject>Intensive care</subject><subject>Lactates - blood</subject><subject>Liver</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Oxygen Consumption - drug effects</subject><subject>Patients</subject><subject>Pharmacology. Drug treatments</subject><subject>Pulmonary arteries</subject><subject>Random Allocation</subject><subject>Splanchnic Circulation - drug effects</subject><subject>Surgical apparatus & instruments</subject><subject>Veins & arteries</subject><issn>0342-4642</issn><issn>1432-1238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp90U1LHTEUBuAgit6qyy4LAUvpZmq-J7Ms0g9BcGPXQ27mxEYyyZjMUG_7583gRWgXXYVDnpxwzovQW0o-UULay0II5YIQSThrD9CGCs4ayrg-RBvCBWuEEuwEvSnlocpWSXqMjjuiOWN6g_5cRxcWiBZwchhievJjirWIuOzKDKO32MQBlymYaH_GWqan3T1EvMw--N9m9pWuAuKQ5vo84gwBTAHsUgjpl4_32Jo8-DQtofY2eYe3u8mUcoaOnAkFzvfnKfrx9cvd1ffm5vbb9dXnm8ZySuam67ZSQCcpH6xTZgsDF05qPjA3CGOJVk6I1lmtqeyccrQDpa1g2rYdbSXnp-jDS98pp8cFytyPvlgIdSJIS-lbXdehuK7w43_hulVKNBErvfiHPqQlxzpGTwlltMah15-bF2VzKiWD66fsx7qBivo1vf6v9Kp_t--6bEcYXvU-rnr_fn9vijXB5ZqJL6-MKcKlkvwZSpOizw</recordid><startdate>19970301</startdate><enddate>19970301</enddate><creator>LOICK, H. M</creator><creator>MÖLLHOFF, T</creator><creator>BERENDES, E</creator><creator>HAMMEL, D</creator><creator>VAN AKEN, H</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7T7</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>19970301</creationdate><title>Influence of enoximone on systemic and splanchnic oxygen utilization and endotoxin release following cardiopulmonary bypass</title><author>LOICK, H. M ; MÖLLHOFF, T ; BERENDES, E ; HAMMEL, D ; VAN AKEN, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c310t-99b54e9513dcf6abed34f583d2fd4ac086f447fc88159f6f19e68c428c7917533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Aged</topic><topic>Analysis of Variance</topic><topic>Biological and medical sciences</topic><topic>Blood Gas Analysis</topic><topic>Cardiac Output - drug effects</topic><topic>Cardiopulmonary Bypass</topic><topic>Cardiotonic agents</topic><topic>Cardiotonic Agents - administration & dosage</topic><topic>Cardiotonic Agents - pharmacology</topic><topic>Cardiovascular system</topic><topic>Catheters</topic><topic>Coronary vessels</topic><topic>Endotoxins - blood</topic><topic>Enoximone - administration & dosage</topic><topic>Enoximone - pharmacology</topic><topic>Female</topic><topic>Fentanyl</topic><topic>Heart surgery</topic><topic>Hemodynamics - drug effects</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Hypotheses</topic><topic>Intensive care</topic><topic>Lactates - blood</topic><topic>Liver</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Oxygen Consumption - drug effects</topic><topic>Patients</topic><topic>Pharmacology. Drug treatments</topic><topic>Pulmonary arteries</topic><topic>Random Allocation</topic><topic>Splanchnic Circulation - drug effects</topic><topic>Surgical apparatus & instruments</topic><topic>Veins & arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LOICK, H. M</creatorcontrib><creatorcontrib>MÖLLHOFF, T</creatorcontrib><creatorcontrib>BERENDES, E</creatorcontrib><creatorcontrib>HAMMEL, D</creatorcontrib><creatorcontrib>VAN AKEN, H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Intensive care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LOICK, H. M</au><au>MÖLLHOFF, T</au><au>BERENDES, E</au><au>HAMMEL, D</au><au>VAN AKEN, H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influence of enoximone on systemic and splanchnic oxygen utilization and endotoxin release following cardiopulmonary bypass</atitle><jtitle>Intensive care medicine</jtitle><addtitle>Intensive Care Med</addtitle><date>1997-03-01</date><risdate>1997</risdate><volume>23</volume><issue>3</issue><spage>267</spage><epage>275</epage><pages>267-275</pages><issn>0342-4642</issn><eissn>1432-1238</eissn><coden>ICMED9</coden><abstract>We investigated whether the administration of enoximone during and after cardiopulmonary bypass (CPB) improves splanchnic oxygen utilization and thereby gut mucosal integrity in humans by its vasodilating and inotropic properties.
Surgical intensive care unit (ICU) in a university hospital.
21 patients (ASA III classification) scheduled for elective coronary artery bypass grafting were enrolled in the study. After induction of general anesthesia, patients were randomly assigned to received a bolus of 0.2 mg/kg enoximone, followed by 5 microg/kg per min (enoximone group), or followed by an equal volume of saline (NaCl group) during and 24 h after the surgical procedure. The following parameters were evaluated at different time intervals: systemic and pulmonary hemodynamics, blood gas analysis of arterial, mixed venous, and liver venous blood, venous and liver venous lactate level, venous and liver venous endotoxin level and intramucosal partial pressure of carbon dioxide for calculation of intramucosal pH (pHi).
Enoximone raised cardiac output and oxygen delivery to higher levels than those observed in the NaCl group. In both groups, gastric pHi fell continuously during the study period. The values were significantly decreased 12 h following admission to the ICU. Endotoxin was not detectable at baseline. Both groups showed increased endotoxin levels, with the highest values during the first 6 h postoperatively. The hepatic venous endotoxin level was almost doubled in the NaCl group in comparison to the enoximone group. Endotoxin levels differed in the two groups 6 and 12 h after admission to the ICU.
Improvement of oxygen delivery by enoximone did not prevent gastric mucosal acidosis following CPB. However, since the increase in endotoxin levels in liver venous blood was diminished by using enoximone, the drug seems to have a beneficial effect on tissue damage and barrier function of the gut.</abstract><cop>Heidelberg</cop><cop>Berlin</cop><pub>Springer</pub><pmid>9083228</pmid><doi>10.1007/s001340050327</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0342-4642 |
ispartof | Intensive care medicine, 1997-03, Vol.23 (3), p.267-275 |
issn | 0342-4642 1432-1238 |
language | eng |
recordid | cdi_proquest_miscellaneous_78908638 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Aged Analysis of Variance Biological and medical sciences Blood Gas Analysis Cardiac Output - drug effects Cardiopulmonary Bypass Cardiotonic agents Cardiotonic Agents - administration & dosage Cardiotonic Agents - pharmacology Cardiovascular system Catheters Coronary vessels Endotoxins - blood Enoximone - administration & dosage Enoximone - pharmacology Female Fentanyl Heart surgery Hemodynamics - drug effects Humans Hydrogen-Ion Concentration Hypotheses Intensive care Lactates - blood Liver Male Medical sciences Middle Aged Oxygen Consumption - drug effects Patients Pharmacology. Drug treatments Pulmonary arteries Random Allocation Splanchnic Circulation - drug effects Surgical apparatus & instruments Veins & arteries |
title | Influence of enoximone on systemic and splanchnic oxygen utilization and endotoxin release following cardiopulmonary bypass |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T02%3A14%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influence%20of%20enoximone%20on%20systemic%20and%20splanchnic%20oxygen%20utilization%20and%20endotoxin%20release%20following%20cardiopulmonary%20bypass&rft.jtitle=Intensive%20care%20medicine&rft.au=LOICK,%20H.%20M&rft.date=1997-03-01&rft.volume=23&rft.issue=3&rft.spage=267&rft.epage=275&rft.pages=267-275&rft.issn=0342-4642&rft.eissn=1432-1238&rft.coden=ICMED9&rft_id=info:doi/10.1007/s001340050327&rft_dat=%3Cproquest_cross%3E78908638%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1012105083&rft_id=info:pmid/9083228&rfr_iscdi=true |